Ankeny, IA, United States of America

Eric Weaver

This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: The Lauridsen Group Incorporated. Active years: 2017-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eric Weaver. Retrieved from https://idiyas.com/inventor/eric-weaver-ggf830h3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 66.7

 

Average Co-Inventor Count = 3.7

ph-index = 1


Company Filing History:


Years Active: 2017-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Eric Weaver: Innovator in Medical Treatments

Introduction

Eric Weaver is a notable inventor based in Ankeny, IA (US). He has made significant contributions to the field of medical treatments, particularly in addressing clostridium difficile associated diseases. With a total of 3 patents to his name, Weaver's work is recognized for its innovative approaches to healthcare.

Latest Patents

Weaver's latest patents include methods and compositions for treating clostridium difficile associated disease. The present invention provides methods for treating and preventing the reoccurrence of infection by administering an immunoglobulin concentrate in conjunction with a low protein diet. This innovative approach aims to improve patient outcomes and reduce the incidence of this challenging infection.

Career Highlights

Eric Weaver is currently associated with The Lauridsen Group Incorporated, where he continues to develop and refine his inventions. His work is characterized by a commitment to advancing medical science and improving treatment options for patients suffering from difficult-to-treat conditions.

Collaborations

Some of his coworkers include Abigail Henderson and Christopher Detzel, who contribute to the collaborative environment that fosters innovation within the company.

Conclusion

Eric Weaver's contributions to medical treatments through his patents demonstrate his dedication to improving healthcare solutions. His innovative methods for treating clostridium difficile associated diseases highlight the importance of research and development in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…